Myeloproliferative Disorders

DBCOND0029888Hemic and Lymphatic DiseasesNeoplasms

Myeloproliferative Disorders is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Myeloproliferative disorders (excl leukaemias) · Myeloproliferative Disorder · Myeloproliferative Neoplasms · Myeloproliferative Disorders (MPD) · Myeloproliferative Neoplasm
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0014332ICD-10D47.1SNOMED CT109993000MedDRA10028578UMLSC0027022

What you can answer from here — as of November 12, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
559Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Myeloproliferative Disorders share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In